Theodore N. Tsangaris, MD, FACS

Contact Dr. Tsangaris

1100 Walnut Street
3rd Floor
Philadelphia, PA 19107

(215) 955-6999
(215) 627-3925 fax

Most Recent Peer-reviewed Publications

  1. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
  2. Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?
  3. Quality-of-life outcomes improve with nipple-sparing mastectomy and breast reconstruction
  4. Economic impact of routine cavity margins versus standard partial mastectomy in breast cancer patients: Results of a randomized controlled trial
  5. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
  6. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma in Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y
  7. Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?
  8. A randomized, controlled trial of cavity shave margins in breast cancer
  9. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs
  10. Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases
  11. The number of lymph nodes dissected in breast cancer patients influences the accuracy of prognosis
  12. PARP inhibitors for chemoprevention - Letter
  13. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
  14. Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer
  15. Does time to definitive treatment matter in patients with ductal carcinoma in situ?
  16. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively
  17. Breast cancer: Preclinical and clinical evaluation of intraductally administered agents in early breast cancer
  18. Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer
  19. A targeted proteomics approach for biomarker discovery using bilateral matched nipple aspiration fluids
  20. A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient